From: Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy
Type of Study
Value
95% Confidence Limits
Cohort
2.4107
0.9554
Sample Size = 29
